The U.S. government is turning its back on a medical breakthrough that has saved millions of lives, halting $500 million in ...

The launch of BIRSA 101 marks a major breakthrough in CRISPR gene-editing technology, positioning India to deliver affordable ...

ARMR Sciences of New York is trialing a vaccine in the Netherlands to protect against fentanyl-related overdose and death.

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

Several of the environmental advocates and vaccine skeptics who helped propel Kennedy into politics have become impatient with what they view as inadequate action on their priorities.

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

For the nine months ended September 30, 2025, CureVac recorded revenues of €43.3 million from GSK, €11.1 million from BioNTech, and €1.8 million from CRISPR Therapeutics, compared with €508.3 million, ...

Mirkin is one of only two Northwestern University faculty members to receive this prestigious award. He joins professor and IIN-affiliated faculty member Tobin J. Marks, who received the 2017 Harvey ...

This list exemplifies the hard work in science over this past year, not simply in the lab but where it matters.